---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-039089"
form_type: "8-K"
ticker: "FCHS"
cik: "0001416876"
company_name: "First Choice Healthcare Solutions, Inc."
filed_at: "2026-08-19T10:07:35+00:00"
generated_at: "2026-08-19T10:10:39.663496+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# First Choice Healthcare signs amended deal to buy Pointe Medical, Trulife Pharmacy for up to $21.3M

## Summary
- Purchase price up to $21.306M: $7M cash closing (less $300k advances), $3M deferred cash, $4.306M assumed debt, $3.5M equity, $2.5M minority stock, $1M performance bonus.
- Acquires Pointe Medical Services, Pointe Med Pharmacy, Livewell MD, and Live Well Drugstore (Trulife Pharmacy) from Gary C. Bernard, M.D.
- Closing conditioned on consummation of Business Combination with Westin Acquisition Corp. and effectiveness of Form F-4 registration statement.
- Outside date is 120 days from July 22, 2026, extendable to 180 days if F-4 remains under SEC review.
- Seller subject to non-compete/non-solicit for 3 years post-close; indemnification cap 10% of purchase price.

## SEC filing metadata
- accession: 0001493152-26-039089
- form_type: 8-K
- ticker: FCHS
- cik: 0001416876
- company_name: First Choice Healthcare Solutions, Inc.
- filed_at: 2026-08-19T10:07:35+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1416876/000149315226039089/0001493152-26-039089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1416876/000149315226039089/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-039089
- JSON: https://secwatch.observer/filing/0001493152-26-039089.json
- Plain text: https://secwatch.observer/filing/0001493152-26-039089.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.